|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Jul 31, 2025
|
Q1 FY2026
As of Oct 31, 2025
|
Q3 FY2025
As of Apr 30, 2025
|
Q2 FY2025
As of Jan 31, 2025
|
Q1 FY2025
As of Oct 31, 2024
|
Q4 FY2024
As of Jul 31, 2024
|
Q3 FY2024
As of Apr 30, 2024
|
Q2 FY2024
As of Jan 31, 2024
|
Q1 FY2024
As of Oct 31, 2023
|
Q4 FY2023
As of Jul 31, 2023
|
Q3 FY2023
As of Apr 30, 2023
|
Q2 FY2023
As of Jan 31, 2023
|
Q1 FY2023
As of Oct 31, 2022
|
Q4 FY2022
As of Jul 31, 2022
|
Q3 FY2022
As of Apr 30, 2022
|
Q2 FY2022
As of Jan 31, 2022
|
Q1 FY2022
As of Oct 31, 2021
|
Q4 FY2021
As of Jul 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Current liabilities – discontinued operations | ||||||||||||||||||||
| Notes payable – related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Convertible note | ||||||||||||||||||||
| Notes Payable - accrued interest | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes Payable - accrued interest | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Notes payable – related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes payable – related parties | ||||||||||||||||||||
| Accrued interest – related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accrued interest – related parties | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common Stock, par value $0.01 per share; 400,000,000 shares authorized; 1,032,640 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders’ deficit | ||||||||||||||||||||
| Total liabilities and shareholders’ deficit | ||||||||||||||||||||
Loading...
